Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Comment by Canuck21Con Aug 15, 2017 12:06pm
153 Views
Post# 26583266

RE:RE:Inspection

RE:RE:InspectionIt's good that you mentioned AXIM, Redbear11.  I have to admit that I haven't spent any time looking at the competition. I've been distracted with other matters that demanded more immediate attention.

At first glance, AXIM and its parent MJNA look like true powerhouse businesses!  Product diversity, international reach, and living up to their claim as being companies of "firsts."  Impressive.  Examining them a little deeper, you can readily see that they may have overreached their ability to execute all their product plans.  The main reason for that is they are drastically underfunded.  The SP on both stocks reflects this although granted half of this was caused by the current malaise experienced by the entire sector.  Being bullish on this industry for the long term, I suspect this is only a temporary (several months to a year?) but painful dip for them.  They will need to raise a LOT more money but that is something that likely won't happen until this sector returns to general favourability.  

A second, more notable thing I found (as a LDS shareholder), was the potential deficiencies of their cannabinoid chewing gum product line.  I heard previously that this patented delivery system could be inferior to that of LDS.  I will look into that more closely but I can see that if that product line experiences any sales declines as a direct result that it can't compete with superior innovations, then those two equities (since they are so closely linked) could be in trouble.  

Bullboard Posts